Wells Fargo Upgrades Achillion Pharmaceuticals (ACHN) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Piper Jaffray Upgrades Achillion Pharmaceuticals (ACHN) to Overweight
August 11, 2014 7:02 AM EDTPiper Jaffray upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Neutral to Overweight with a price target of $10.00 (from $5.00). Analyst Edward A. Tenthoff thinks potential suitors could emerge soon.
"Achillion ended 2Q:14 with cash of $131.5 million to advance its emerging HCV pipeline. Achillion... More
Achillion Pharmaceuticals, Inc. (ACHN) Tops Q2 EPS by 2c
August 7, 2014 4:27 PM EDTAchillion Pharmaceuticals, Inc. (NASDAQ: ACHN) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Achillion Pharmaceuticals, Inc. (ACHN) click here.
... More